Seoul National University Hospital: Renal Insufficiency trials
The registry lists 11 Renal Insufficiency studies with Seoul National University Hospital as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 3 1Phase 4 3No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Artificial Intelligence-based Prediction of Radio-cephalic Arteriovenous Fistula Maturation Using Preoperative Duplex ExaminationCompletedNCT06600750
- Postoperative Troponin in Renal Dysfunction After Cardiac SurgeryCompletedNCT03540511
- Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line HemodiafiltrationCompletedNCT03448887Not applicable
- HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse ReactionStatus unknownNCT03046914Not applicable
- Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial)CompletedNCT02799368Phase 3
- Effect of Ambulatory BP Monitoring on the CliniCal coUrse and RenAl ouTcomE of CKDStatus unknownNCT02417571Not applicable
- Pilot Study of Contrast-Enhanced Ultrasound of Transplanted KidneyStatus unknownNCT01883583Not applicable
- Effects of HIgh Volume COntinuous REnal Replacement Therapy in Patients With Septic Acute Kidney InjuryCompletedNCT01191905Not applicable
- NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary CatheterizationCompletedNCT00356954Phase 4
- PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary AngiographyCompletedNCT00259441Phase 4
- RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary AngiographyCompletedNCT00247325Phase 4